Skip to main content
. Author manuscript; available in PMC: 2018 Jun 4.
Published in final edited form as: Leukemia. 2017 Jul 12;32(2):353–363. doi: 10.1038/leu.2017.222

Table 1.

Clinical characteristics of patients grouped by type of BM involvement

Characteristics Negative BM (n = 449) No. (%) Concordant BM (n = 173) No. (%) Discordant BM (n = 90) No. (%) P value
Advanced DLBCL & Negative BM (n = 212) No. (%) P value
Neg v Con Neg v Dis Con v Dis Adv-Neg v Con Adv-Neg v Dis
Age (years)

 Median 62.6 63.0 63.0 0.841 0.715 0.838 62.0 0.950 0.814

 Range 16–89 25–91 31–89 17–89
Sex

 Male 267 (59.5) 81 (46.8) 54 (60.0) 0.004 0.925 0.042 123 (58.0) 0.029 0.749

 Female 182 (40.5) 92 (53.2) 37 (40.0) 89 (42.0)
IPI factors

 Age >60 years 255 (56.8) 101 (58.4) 51 (56.7) 0.720 0.982 0.789 121 (57.1) 0.911 0.948

 LDH elevated 240 (57.4) 138 (80.2) 34 (38.2) <0.001 0.001 <0.001 134 (66.0) 0.003 <0.001

 Stage III–IV 212 (47.9) 173 (100.0) 90 (100.0) <0.001 <0.001 1.000 212 (100.0) 1.000 1.000

 ECOG PS ≥2 53 (12.8) 63 (36.6) 10 (11.2) <0.001 0.691 <0.001 39 (19.7) <0.001 0.078

 Extranodal sites >1 63 (14.1) 115 (66.5) 55 (61.1) <0.001 <0.001 0.388 61 (28.9) <0.001 <0.001

IPI score

 Low (0–1) 173 (39.9) 6 (3.5) 11 (12.4) <0.001 <0.001 <0.001 21 (10.2) <0.001 0.861

 Intermediate (2–3) 214 (49.3) 85 (49.4) 58 (65.1) 138 (67.4)

 High (4–5) 47 (10.8) 81 (47.1) 20 (22.5) 46 (22.4)

Bulky mass ≥7cm 108 (28.5) 50 (30.1) 28 (31.1) 0.700 0.623 0.869 60 (32.8) 0.586 0.781

B symptoms 141 (32.4) 100 (58.1) 18 (20.0) <0.001 0.02 <0.001 97 (46.6) 0.028 <0.001

Abbreviations: Neg, negative BM involvement; Con, concordant BM involvement; Dis, discordant BM involvement; Adv-Neg, advanced DLBCL with negative BM involvement